Literature DB >> 11696455

Loss of heterozygosity on chromosomes 9q and 16p in atypical adenomatous hyperplasia concomitant with adenocarcinoma of the lung.

K Takamochi1, T Ogura, K Suzuki, H Kawasaki, Y Kurashima, T Yokose, A Ochiai, K Nagai, Y Nishiwaki, H Esumi.   

Abstract

Atypical adenomatous hyperplasia (AAH) has recently been implicated as a precursor to lung adenocarcinoma. We previously reported loss of heterozygosity (LOH) in tuberous sclerosis (TSC) gene-associated regions to frequently be observed in lung adenocarcinoma with multiple AAHs. In this study, we analyzed LOH in four microsatellite loci on 9q, including the TSC1 gene-associated region, and four loci on 16p, including the TSC2 gene-associated region, in both 18 AAHs and 17 concomitant lung adenocarcinomas from 11 patients. Seven of 18 (39%) AAHs and 9 of 17 (53%) adenocarcinomas displayed LOH on 9q. Five (28%) AAHs and seven (41%) adenocarcinomas harbored LOH at loci adjacent to the TSC1 gene. Four of 18 (22%) AAHs and 6 of 17 (35%) adenocarcinomas displayed LOH on 16p. One (6%) AAH and five (29%) adenocarcinomas harbored LOH at loci adjacent to the TSC2 gene. These findings may indicate a causal relationship of LOH on 9q and 16p in a fraction of AAH lesions and adenocarcinomas of the lung. Especially, the frequencies of LOH on 9q and at the TSC1 gene-associated region were high. The TSC1 gene or another neighboring tumor suppressor gene on 9q might be involved in an early stage of the pathogenesis of lung adenocarcinoma.

Entities:  

Mesh:

Year:  2001        PMID: 11696455      PMCID: PMC1867041          DOI: 10.1016/S0002-9440(10)63041-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  Deletions of 17p and p53 mutations in preneoplastic lesions of the lung.

Authors:  G Sozzi; M Miozzo; R Donghi; S Pilotti; C T Cariani; U Pastorino; G Della Porta; M A Pierotti
Journal:  Cancer Res       Date:  1992-11-01       Impact factor: 12.701

2.  Isolation and characterisation of (AC)n microsatellite genetic markers from human chromosome 16.

Authors:  A D Thompson; Y Shen; K Holman; G R Sutherland; D F Callen; R I Richards
Journal:  Genomics       Date:  1992-06       Impact factor: 5.736

3.  Bronchioloalveolar cell adenomas.

Authors:  R R Miller
Journal:  Am J Surg Pathol       Date:  1990-10       Impact factor: 6.394

4.  A high-resolution linkage map of human 9q34.1.

Authors:  E P Henske; L Ozelius; J F Gusella; J L Haines; D J Kwiatkowski
Journal:  Genomics       Date:  1993-09       Impact factor: 5.736

5.  High prevalence of atypical adenomatous hyperplasia of the lung in autopsy specimens from elderly patients with malignant neoplasms.

Authors:  T Yokose; Y Ito; A Ochiai
Journal:  Lung Cancer       Date:  2000-08       Impact factor: 5.705

6.  p53 mutation and allelic loss of chromosome 3p, 9p of preneoplastic lesions in patients with nonsmall cell lung carcinoma.

Authors:  H Kohno; K Hiroshima; T Toyozaki; T Fujisawa; H Ohwada
Journal:  Cancer       Date:  1999-01-15       Impact factor: 6.860

7.  p53 protein accumulates frequently in early bronchial neoplasia.

Authors:  W P Bennett; T V Colby; W D Travis; A Borkowski; R T Jones; D P Lane; R A Metcalf; J M Samet; Y Takeshima; J R Gu
Journal:  Cancer Res       Date:  1993-10-15       Impact factor: 12.701

8.  Pulmonary lymphangioleiomyomatosis and Bourneville's tuberous sclerosis with pulmonary involvement: the same disease?

Authors:  F Capron; J Ameille; P Leclerc; P Mornet; M Barbagellata; M Reynes; J Rochemaure
Journal:  Cancer       Date:  1983-09-01       Impact factor: 6.860

9.  Morphometric study of adenocarcinomas and hyperplastic epithelial lesions in the peripheral lung.

Authors:  T Kodama; S Biyajima; S Watanabe; Y Shimosato
Journal:  Am J Clin Pathol       Date:  1986-02       Impact factor: 2.493

10.  Causes of death in patients with tuberous sclerosis.

Authors:  C W Shepherd; M R Gomez; J T Lie; C S Crowson
Journal:  Mayo Clin Proc       Date:  1991-08       Impact factor: 7.616

View more
  19 in total

1.  Tuberous sclerosis complex 2 loss of heterozygosity in patients with lung disease and cancer.

Authors:  Li Zhang; Gustavo Pacheco-Rodriguez; Wendy K Steagall; Jiro Kato; Mary Haughey; Joseph R Fontana; Vincent C Manganiello; Joel Moss
Journal:  Am J Respir Crit Care Med       Date:  2015-02-01       Impact factor: 21.405

Review 2.  International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.

Authors:  William D Travis; Elisabeth Brambilla; Masayuki Noguchi; Andrew G Nicholson; Kim R Geisinger; Yasushi Yatabe; David G Beer; Charles A Powell; Gregory J Riely; Paul E Van Schil; Kavita Garg; John H M Austin; Hisao Asamura; Valerie W Rusch; Fred R Hirsch; Giorgio Scagliotti; Tetsuya Mitsudomi; Rudolf M Huber; Yuichi Ishikawa; James Jett; Montserrat Sanchez-Cespedes; Jean-Paul Sculier; Takashi Takahashi; Masahiro Tsuboi; Johan Vansteenkiste; Ignacio Wistuba; Pan-Chyr Yang; Denise Aberle; Christian Brambilla; Douglas Flieder; Wilbur Franklin; Adi Gazdar; Michael Gould; Philip Hasleton; Douglas Henderson; Bruce Johnson; David Johnson; Keith Kerr; Keiko Kuriyama; Jin Soo Lee; Vincent A Miller; Iver Petersen; Victor Roggli; Rafael Rosell; Nagahiro Saijo; Erik Thunnissen; Ming Tsao; David Yankelewitz
Journal:  J Thorac Oncol       Date:  2011-02       Impact factor: 15.609

3.  A novel functional DEC1 promoter polymorphism -249T>C reduces risk of squamous cell carcinoma of the head and neck.

Authors:  Yu-Jing Huang; Jiangong Niu; Sheng Wei; Ming Yin; Zhensheng Liu; Li-E Wang; Erich M Sturgis; Qingyi Wei
Journal:  Carcinogenesis       Date:  2010-10-08       Impact factor: 4.944

4.  Mitochondrial ribosomal protein L41 suppresses cell growth in association with p53 and p27Kip1.

Authors:  Young A Yoo; Mi Jin Kim; Jong Kuk Park; Young Min Chung; Jong Hyeok Lee; Sung-Gil Chi; Jun Suk Kim; Young Do Yoo
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

5.  Overexpression of phospho-eIF4E is associated with survival through AKT pathway in non-small cell lung cancer.

Authors:  Akihiko Yoshizawa; Junya Fukuoka; Shigeki Shimizu; Konstantin Shilo; Teri J Franks; Stephen M Hewitt; Takeshi Fujii; Carlos Cordon-Cardo; Jin Jen; William D Travis
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

Review 6.  Concordant and Discordant EGFR Mutations in Patients With Multifocal Adenocarcinomas: Implications for EGFR-Targeted Therapy.

Authors:  Jody C Chuang; Joseph B Shrager; Heather A Wakelee; Joel W Neal
Journal:  Clin Ther       Date:  2016-06-29       Impact factor: 3.393

Review 7.  Growth controls connect: interactions between c-myc and the tuberous sclerosis complex-mTOR pathway.

Authors:  Emmett V Schmidt; Michael J Ravitz; Li Chen; Mary Lynch
Journal:  Cell Cycle       Date:  2009-05-18       Impact factor: 4.534

Review 8.  C4.4A as a biomarker in pulmonary adenocarcinoma and squamous cell carcinoma.

Authors:  Benedikte Jacobsen; Mette Camilla Kriegbaum; Eric Santoni-Rugiu; Michael Ploug
Journal:  World J Clin Oncol       Date:  2014-10-10

9.  DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma.

Authors:  Suhaida A Selamat; Janice S Galler; Amit D Joshi; M Nicky Fyfe; Mihaela Campan; Kimberly D Siegmund; Keith M Kerr; Ite A Laird-Offringa
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

10.  TSC1 loss synergizes with KRAS activation in lung cancer development in the mouse and confers rapamycin sensitivity.

Authors:  M-C Liang; J Ma; L Chen; P Kozlowski; W Qin; D Li; J Goto; T Shimamura; D N Hayes; M Meyerson; D J Kwiatkowski; K-K Wong
Journal:  Oncogene       Date:  2009-12-07       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.